TriSalus Life Sciences, Inc. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)
TriSalus Life Sciences, Inc. (TLSI) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of -$6.71 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2024-08-14
- TriSalus Life Sciences, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2024-06-30 was -$9.41M.
- TriSalus Life Sciences, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2024-03-31 was $2.70M.
| Period end | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month |
|---|---|---|
| 2024-06-30 | -$9.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$6.71M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |